![Gregory Gorgas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregory Gorgas
Chief Executive Officer at ARTELO BIOSCIENCES, INC.
Net worth: 28 011 $ as of 30/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Emanuele | M | 69 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 13 years |
James Plante | M | - |
Klotho Therapeutics, Inc.
![]() Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Klotho Therapeutics, Inc. operates as a biotechnology company. It develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease. The company was founded by James Plante in 2016 and is headquartered in San Diego, CA. | - |
Connie Matsui | F | 70 | 7 years | |
Steven Kelly | M | 59 | 7 years | |
Gregory Reyes | M | 70 | 4 years | |
Susan Alexander | F | 67 | 21 years | |
Tamara Favorito | F | 65 | 3 years | |
Douglas Blayney | M | 73 | 7 years | |
Jason Baybutt | M | 52 | 2 years | |
Steven D. Reich | M | - | 6 years | |
Michael Dambach | M | 57 | 17 years | |
Andy Yates | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Peter O’Brien | M | 45 | 5 years | |
Patrick Keran | M | 52 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 years |
James Tobin | M | 79 | 5 years | |
William Young | M | 79 | 11 years | |
William Rastetter | M | 75 | 19 years | |
Stelios Papadopoulos | M | 75 | 15 years | |
Georgia Erbez | F | 57 | 2 years | |
Ted Love | M | 65 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 1 years |
Howard C. Dittrich | M | 71 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 3 years |
Michael Kelly | M | 67 | 2 years | |
Gilmore O’Neill | M | 59 | 15 years | |
Lynne Sullivan | F | 58 | 10 years | |
John W. Beck | M | 64 | 2 years | |
Robert A. Hamm | M | 72 | 7 years | |
Peter Greenleaf | M | 54 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
Eric S. Hoffman | M | 54 | 5 years | |
Paul Clancy | M | 62 | 16 years | |
Samantha Truex | F | - | 8 years | |
Brian Posner | M | 62 | 14 years | |
Sylvie Grégoire | M | 62 | 8 years | |
Jack Lief | M | 78 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 years |
Lewis J. Shuster | M | 68 |
Mast Therapeutics, Inc.
![]() Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 5 years |
Nancy L. Leaming | F | 76 | 14 years | |
James L. Vincent | M | 84 | 12 years | |
Robert W. Pangia | M | 72 | 24 years | |
Craig Eric Schneier | M | 76 | 8 years | |
Joseph Mara | M | 49 | - | |
William Mccarthy | M | - | 1 years | |
Matthew P. Ottmer | M | 53 | 16 years | |
Diego Cadavid | M | 58 | 8 years | |
Ben Harshbarger | M | 55 | 5 years | |
Mark Meltz | M | 50 | 5 years | |
Ed Dondero | M | - | - | |
Richard Francis | M | 55 | 8 years | |
Maiken Keson-Brookes | F | 52 | 5 years | |
Michael Panzara | M | 57 | 8 years | |
Scott Anthony Climes | M | 59 | 2 years | |
Christopher Watt | M | 59 | 11 years | |
Mark Bodenrader | M | 51 | - | |
Johanna Friedl-Naderer | F | 56 | 21 years | |
Paula Cobb | F | 51 | 13 years | |
Andrea DiFabio | F | 55 | 11 years | |
Michael Pollock | M | - | 2 years | |
Richard Brudnick | M | 67 | 15 years | |
Joseph J. Kenny | M | - | 5 years | |
Alexey A. Lugovskoy | M | 51 | 9 years | |
Michael Cloonan | M | 53 | 14 years | |
Gisele Dion | F | 57 | 9 years | |
Barry Ticho | M | 64 | 13 years | |
Esther Alegria | M | 66 | 10 years | |
Liisa I. Nogelo | F | 53 | 11 years | |
Lisa Amaya Price | F | - | 8 years | |
James Basta | M | 58 | - | |
Thomas F. Keller | M | 92 | - | |
Pratik Multani | M | 57 | 5 years | |
John Cox | M | 61 | 14 years | |
Nancy Simonian | M | 63 | 6 years | |
Robert Perez | M | 59 | 8 years | |
Michael Gilman | M | 69 | 6 years | |
Anne Cook | F | 62 | 13 years | |
Michael D. Kowolenko | M | 68 | - | |
Raymond Pawlicki | M | 63 | 6 years | |
Alan B. Glassberg | M | 87 | 12 years | |
Bruce R. Ross | M | 83 | 13 years | |
Burt Adelman | M | 71 | 16 years | |
John Dunn | M | 72 | 9 years | |
John Maraganore | M | 60 | 10 years | |
Peter Kellogg | M | 67 | 4 years | |
Cecil B. Pickett | M | 78 | 3 years | |
Hans-Peter Hasler | M | 68 | 8 years | |
Michael Kauffman | M | 60 | 2 years | |
David Hallal | M | 56 | 2 years | |
Alfred Sandrock | M | 67 | 23 years | |
Jennifer A. Spinella | F | - | - | |
Michael MacLean | M | 58 | 4 years | |
Elizabeth Woo | F | 57 | 12 years | |
Keith Regnante | M | 54 | 14 years | |
Daniel Char | M | 63 | 11 years | |
Mark Wiggins | M | 68 | 11 years | |
Akshay Vaishnaw | M | 61 | 7 years | |
Michael Rudolf | M | - | - | |
John Leonard | M | 77 | 15 years | |
John McCabe | M | 55 | 2 years | |
William Sibold | M | 57 | - | |
Eric W. Kimble | M | 58 | 5 years | |
Alain J. Gilbert | M | - | 5 years | |
Robert Gagnon | M | 49 | 7 years | |
Bethany Sensenig | F | 48 | 13 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gregory Gorgas
- Personal Network